Keith Stuart
Lahey Hospital & Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Keith Stuart as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04844970 · Anamorelin Study for Advanced Pancreatic CancerLahey Clinic · terminated · Metastatic Pancreatic Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in pancreatic cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:51 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- Activity of sunitinib in patients with advanced neuroendocrine tumors.J Clin Oncol · 2008485 citationsRCR 12.8
- Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.J Clin Oncol · 2006411 citationsRCR 11.2
- A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma.Cancer · 199883 citationsRCR 2.6
- 65 citationsRCR 2.1
- 28 citationsRCR 0.7